Ortivus

Ortivus Equity

The The Equity of Ortivus (ORTI B.ST) as of Nov 19, 2026 is 22.41 M SEK. In the previous year, The Equity was -7.17 M SEK — a change of -412.83% (higher).

Equity

22.41 MSEK

YoY

-412.83%

Last updated:

In 2025, Ortivus's equity was 22.41 M SEK, a -412.83% increase from the -7.17 M SEK equity in the previous year.

The Ortivus Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
2.18 M SEK
Jan 1, 2019
8.75 M SEK
Jan 1, 2020
19.68 M SEK
Jan 1, 2021
29.44 M SEK
Jan 1, 2022
35.44 M SEK
Jan 1, 2023
17.31 M SEK
Jan 1, 2024
-7.17 M SEK
Jan 1, 2025
22.41 M SEK
The Ortivus Equity history
YEAREquityYoY
22.41 MSEK-412.83%
-7.17 MSEK-141.40%
17.31 MSEK-51.16%
35.44 MSEK+20.35%
29.44 MSEK+49.63%
19.68 MSEK+124.79%
8.75 MSEK+301.38%
2.18 MSEK-85.98%
15.56 MSEK+197.87%
5.22 MSEK-57.76%
12.36 MSEK-36.10%
19.35 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ortivus Stock analysis

What does Ortivus do? Ortivus AB develops and sells clinical devices and systems, including MobiMed Smart, a decision support system for ambulance personnel to handle documentation, monitoring, and structured prehospital care. CoroNet is a mobile surveillance solution enabling patients to move freely under medical supervision while providing healthcare professionals with real-time monitoring data. The company offers additional services like support, implementation, training, and consulting. Its primary customers are ambulance services and emergency departments. Ortivus AB generates revenue through the sale of MobiMed Smart and CoroNet systems, along with associated services. Ambulance services and emergency departments purchase these products to improve prehospital care documentation and patient monitoring. The decision support system MobiMed Smart streamlines ambulance operations, while CoroNet enhances patient supervision in healthcare settings, addressing key needs for efficient medical response and care management. The company's revenue model relies on direct sales of its clinical systems and supplementary services to healthcare providers. MobiMed Smart targets ambulance personnel for prehospital care documentation, and CoroNet serves healthcare professionals needing mobile patient monitoring. These products are tailored to the specific operational requirements of ambulance services and emergency departments, ensuring alignment with their workflows and care standards. Ortivus is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Ortivus's Equity

Ortivus's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ortivus's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Ortivus's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Ortivus's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Ortivus’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Ortivus stock

The Equity of Ortivus is 22.41 M SEK in 2025.

The Equity of Ortivus changed from -7.17 M SEK to 22.41 M SEK, representing a -412.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Ortivus since 2006 – with annual values, charts, and detailed analysis.

The Equity's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Ortivus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Ortivus

All Key Metrics — Ortivus